UMIN ID: C000000331
Registered date:21/02/2006
The protective effects of Telmisartan on the cardiovascular system
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Hypertension |
| Date of first enrollment | 2006/01/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | treatment with Telmisartan treatment with Losartan |
Outcome(s)
| Primary Outcome | blood pressure, cardiovascular clinical event,cardiac hypertrophy, cardiac function, atherosclerosis,insulin resistance, renal function |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 30years-old |
|---|---|
| Age maximum | 70years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | *Secondary hypertension *heart failure *diabetes mellitus *acute myocardial infarction within 6 months *treated with PCI within 6 months *cerebrovascular disease within 3 months *severe renal failure (serum creatinine>3mg/dl *severe hepatic failure *malignant disease |
Related Information
| Primary Sponsor | Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Ministry of Education, Science, Sports, and Culture |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroshi Hasegawa |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba Japan |
| Telephone | 0432227171 |
| hasegawa-chiba@umin.ac.jp | |
| Affiliation | Chiba University Graduate School of Medicine Cardiovascular Science and Medicine |
| scientific contact | |
| Name | Hiroshi Hasegawa |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba Japan |
| Telephone | 0432227171 |
| hasegawa-chiba@umin.ac.jp | |
| Affiliation | Chiba University Graduate School of Medicine Cardiovascular Science and Medicine |